Boothbay Fund Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.27M Buy
580,137
+352,429
+155% +$6.94M 0.15% 162
2026
Q2
$5.83M Sell
227,708
-372,271
-62% -$8.76M 0.08% 304
2026
Q1
$8.98M Buy
599,979
+36,823
+7% +$628K 0.12% 161
2025
Q4
$8.2M Sell
563,156
-122,414
-18% -$2.13M 0.12% 175
2025
Q3
$12.3M Buy
685,570
+645,165
+1,597% +$9.46M 0.18% 113
2025
Q2
$690K Sell
40,405
-767,051
-95% -$7.68M 0.01% 805
2025
Q1
$5.85M Buy
807,456
+195,391
+32% +$2.22M 0.15% 185
2024
Q4
$8.6M Sell
612,065
-207,468
-25% -$3.07M 0.21% 130
2024
Q3
$9.7M Buy
+819,533
New +$8.49M 0.22% 99
2024
Q2
– Sell
-772,375
Closed -$3.95M – 1577
2024
Q1
$2.73M Buy
+772,375
New +$2.68M 0.05% 404

Other funds holding CORZ

Boothbay Fund Management's CORZ Position: Q3 2026 in Review

Boothbay Fund Management increased its Core Scientific (CORZ) stake by 155% in Q3 2026, buying an estimated $6.94M and bringing the position to 580,137 shares worth $9.27M. The position accounts for 0.15% of the portfolio, ranked #162.

Boothbay Fund Management first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.3M in Q3 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

  • Boothbay Fund Management held 580,137 shares of Core Scientific worth $9.27M as of Q3 2026.
  • Boothbay Fund Management bought 352,429 Core Scientific shares in Q3 2026, an estimated $6.94M.
  • Core Scientific made up 0.15% of Boothbay Fund Management's portfolio in Q3 2026, its #162 holding.
  • Boothbay Fund Management first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Boothbay Fund Management's Core Scientific position peaked at $12.3M in Q3 2025.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.